… Aim of our study was to evaluate toxicity and possible adverse effects from vaccination of
patients with advanced colorectal cancer with autologous dendritic cells (DC) pulsed with …

… allogeneic melanoma cell lysate–pulsed autologous dendritic cell (DC) vaccine clinical study
in MAGE-enriched advanced … We also studied the effects of our DC vaccine on Treg in vivo. …

… vaccination pulsed with an allogeneic tumor lysate in pre-treated MAGE-gene-expressing
advanced colorectal cancer patients … selected patients. Treg levels and PD-1 expression on T …

… Previously, we tested a dendritic cell (DC)-based phase I vaccine, and confirmed that it was
… study, we performed a phase II trial of a DC vaccine for metastatic melanoma patients with …

… Others studies of vaccination with tumor lysate-pulsed DC have shown that CTL are induced
either directly by cross-presentation or as the result of epitope spreading (62). However, as …

… inevaluable patients, 1 patient with colorectal cancer did not receive any vaccines because
… DCs was associated with measurable tumor responses in patients with advanced melanoma…

… The aim of the present phase I/II study was to evaluate the … vaccine based on autologous
dendritic cells (DC) loaded with an allogeneic tumor cell lysate in advanced melanoma patients. …

… study evaluated the safety and effectiveness of tumor-lysate loaded DC vaccines in advanced
colorectal cancer (CRC) patients … melanoma antigens was found in 5 of 11 patients. In our …

… A phase I trial, was aimed to evaluate toxicity and possible … from vaccination of patients with
advanced colorectal cancer with … Vaccination with melanoma lysate-pulsed dendritic cells, of …

… present study was to evaluate the effect of treating patients with advanced colorectal cancer
with a cancer vaccine … MH, et al: Vaccination with melanoma lysate-pulsed dendritic cells, of …